690 results on '"Reindl, Markus"'
Search Results
2. Peripheral inflammatory response in people after acute ischaemic stroke and isolated spontaneous cervical artery dissection
3. Pathogenic autoantibodies in multiple sclerosis — from a simple idea to a complex concept
4. Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving Natalizumab
5. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
6. Factors and strategies affecting motor imagery ability in people with multiple sclerosis: a systematic review
7. Peripheral neuropathy and MOG-IgG: A clinical and neuropathological retrospective study
8. Anti-NMDA receptor encephalitis and MOG-associated demyelination – a case report with long-term follow-up and a systematic review
9. 12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort
10. Actual and Imagined Music-Cued Gait Training in People with Multiple Sclerosis: A Double-Blind Randomized Parallel Multicenter Trial.
11. More Efficient Complement Activation by Anti–Aquaporin-4 Compared With Anti–Myelin Oligodendrocyte Glycoprotein Antibodies
12. Myelin-oligodendrocyte glycoprotein antibody-associated disease
13. Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
14. Antibodies to MOG in CSF only: pathological findings support the diagnostic value
15. 6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort
16. Presence of anti-neuronal antibodies in children with neurological disorders beyond encephalitis
17. MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
18. Body fluid markers for multiple sclerosis and differential diagnosis from atypical demyelinating disorders.
19. Combining specific task-oriented training with manual therapy to improve balance and mobility in patients after stroke: a mixed methods pilot randomised controlled trial.
20. Factors influencing the willingness to adopt telerehabilitation among rehabilitation professionals in Austria and Germany: a survey comparing data before and during COVID-19.
21. Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?
22. Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up
23. Cell-based assays for the detection of MOG antibodies: a comparative study
24. Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
25. German translation, cultural adaptation and validation of the unidimensional self-efficacy scale for multiple sclerosis
26. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
27. Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers
28. High association of MOG-IgG antibodies in children with bilateral optic neuritis
29. Antibody signatures in patients with histopathologically defined multiple sclerosis patterns
30. T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis
31. Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
32. New clinical implications of anti-myelin oligodendrocyte glycoprotein antibodies in children with CNS demyelinating diseases
33. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
34. Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat
35. Myelin oligodendrocyte glycoprotein antibodies in neurological disease
36. Teaching NeuroImages: Bilateral optic neuritis: When to suspect anti-MOG antibodies
37. Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes
38. High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
39. Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis.
40. Antibodies to nodal/paranodal proteins in paediatric immune-mediated neuropathy
41. Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies
42. Are aquaporin antibody titers useful outcome measures for neuromyelitis optica spectrum disorders?
43. International multicenter examination of MOG antibody assays
44. Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases
45. Tocilizumab treatment in severe recurrent anti-MOG-associated optic neuritis
46. Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter
47. MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein
48. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study
49. Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination
50. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.